Users

STOPP Criteria for cardiovascular Drugs

Posted Friday 02 September 2011 - 13:30 PM by David Chan

Description

If the patient isany greater than 64 y of age, and taking any drugs with code atc:C01AA05 (Digoxin), atc:C03CA01 (Furosemide), then consider the following:
Please refer to http://www.em-consulte.com/showarticlefile/245669/main.pdf for details.

Evidence

good to fair

Significance

Very significant

Conditions

Consequence

  1. Warning
    Strength: Warning
    Text: These drugs are potentially inappropriate in persons over 65: digoxin at a long term dose >125 with impaired renal function loop diuretic for dependent ankle edema only or as first line monotherapy for hypertension

Reference

http://www.em-consulte.com/showarticlefile/245669/main.pdf

STOPP Criteria for cardiovascular Drugs

<guideline title="STOPP Criteria for cardiovascular Drugs" evidence="good to fair" significance="very significant"> <conditions> <condition type="age" any="&gt; 64 y" /> <condition type="drugs" any="atc:C01AA05, atc:C03CA01" desc="Digoxin, Furosemide" /> </conditions> <consequence> <warning strength="warning">These drugs are potentially inappropriate in persons over 65: Digoxin at a long term dose &gt;125 with impaired renal function Loop diuretic for dependent ankle edema only or as first line monotherapy for hypertension</warning> </consequence> </guideline>

http://www.em-consulte.com/showarticlefile/245669/main.pdf

Other Versions

  1. STOPP Criteria

    (Updated: 2011-09-02 13:30:06 UTC)

  2. STOPP Criteria for cardiovascular Drugs

    (Updated: 2011-09-02 13:42:02 UTC)

  No comments so far

Search Posts









Get RSS Feeds!

MyDrugRef now offers RSS Feeds. Click here to get them!